Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin

Total article views   Abstract views HTML views PDF downloads Totals
9,800 Dovepress* 6,952 1,149+ 1,745 8,101
PubMed Central* 0 1,699 565 1,699
Totals 6,952 2,848 2,310 9,800
*Since 3 May 2017
+Since July 2016

View citations on PubMed Central and Google Scholar